The global pericardial disease market is anticipated to grow at a CAGR of around 5.5% during the forecast period (2024-2031). The factors attributing to the growth of the market include the growing geriatric population and rising prevalence of the pericardial disease across the globe. According to United Nations, Department of Economic and Social Affairs report for World Population Ageing 2019, by 2050, 1 in 6 people in the world will be over the age of 65, up from 1 in 11 in 2019. In line with this, there were 703 million persons aged 65 years or over in the world in 2019. The number of older persons is projected to double to 1.5 billion in 2050. Globally, the share of the population aged 65 years or over increased from 6.0% in 1990 to 9.0% in 2019. That proportion is projected to rise further to 16.0% by 2050, so that one in six people in the world will be aged 65 years or over. Though, geriatric populations are more vulnerable to pericardial disease creates demands for advanced treatments, thus higher growth in the market can be seen in upcoming years. Moreover, the rising cardiac diseases are expected to increase the sales for the drugs and treatments associated with the diseases.
Get Free Sample link @ https://www.omrglobal.com/request-sample/pericardial-disease-market
By geography, Eastern and South-Eastern Asia and Latin America and the Caribbean are the regions with a higher % of the aged population. In Eastern and South-Eastern Asia, the aged population has increased from 6% in 1990 to 11% in 2019, and from 5% to 9% in Latin America and the Caribbean in respective years. Moreover, the developments in the treatments and FDA approvals to the drugs launched by the market players can be expected to further increase the global pericardial diseases market growth.
Full report of Pericardial Disease Market available @ https://www.omrglobal.com/industry-reports/pericardial-disease-market
Market Coverage
- Segment Covered-
o By Application
o By Function
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Abbott Laboratories, Edwards Lifesciences Corp, Integra LifeSciences Corp, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Pericardial Disease Market Report Segment
By Type
- Acute Pericarditis
- Chronic Pericarditis
- Recurrent Pericarditis
By Diagnosis Method
- Chest X-Ray
- Cardiac MRI
- Cardiac CT Scan
- Echocardiography
- Electrocardiography (EKG)
- Others (Blood Test)
By Treatment Approach
- Nonsteroidal Anti-Inflammatory Agents (NSAIDS) Drugs
- Pericardiectomy
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pericardial-disease-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
